SMAD1 and diabetic kidney disease: In 2019, his group reported that ADSC-exosomes improved diabetic nephropathy symptoms by increasing the expression of miR-486, which led to the inhibition of the Smad1/mTOR (Mothers Against Decapentaplegic family 1/Mammalian target of rapamycin) signaling pathway in podocytes [47].